Stealth Biotherapeutics Corp ADR (MITO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | N/A | N/A | 4,119 |
| Other current assets | 0 | 0 | 1,801 |
| TOTAL | $N/A | $N/A | $5,920 |
| Non-Current Assets | |||
| PPE Net | N/A | N/A | 1,825 |
| Other Non-Current Assets | 0 | 0 | 439 |
| TOTAL | $N/A | $N/A | $2,264 |
| Total Assets | $N/A | $N/A | $7,155 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | N/A | N/A | 2,094 |
| Accounts payable and accrued liabilities | 0 | 0 | 7,455 |
| Accrued Expenses | N/A | N/A | 15,046 |
| TOTAL | $N/A | $N/A | $24,595 |
| Non-Current Liabilities | |||
| Long Term Debt | N/A | N/A | 11,957 |
| Other Non-Current Liabilities | 0 | 0 | 50,513 |
| TOTAL | $N/A | $N/A | $62,470 |
| Total Liabilities | $N/A | $N/A | $87,064 |
| Shareholders' Equity | |||
| Common Shares | N/A | N/A | 21 |
| Retained earnings | N/A | N/A | -329,557 |
| Other shareholders' equity | 0 | 0 | 211,378 |
| TOTAL | $N/A | $N/A | $-79,909 |
| Total Liabilities And Equity | $0 | $0 | $7,155 |